Simon Read

Dr. Simon Read is an Independent Director at Dianthus Therapeutics, Inc., a Scientific Advisory Board Member at Q32 Bio Operations, Inc., a Chief Scientific Officer at RA Pharmaceuticals, Inc., a Member at The Medical Research Council and an Advisor at Atlas Venture Advisors, Inc. He is on the Board of Directors at Dianthus Therapeutics, Inc. Dr. Read was previously employed as a President, Chief Executive Officer & Director by Mariana Oncology, Inc., a VP & Head-Innovative Medicines Unit by Grünenthal GmbH, a Director-Experimental Medicine by Genentech, Inc., and an Associate Director Disease by AstraZeneca LP.
He also served on the board at TRIANA Biomedicines, Inc. He received his undergraduate degree from The University of Manchester, a graduate degree from The University of Southampton and a doctorate degree from the University of Hertfordshire.